Silexion Therapeutics - Warrants(14/08/2029) Return on Equity

Silexion Therapeutics - Warrants(14/08/2029)'s return on equity stands at 11668.18%. That is above the sector sector average of -5.68%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Silexion Therapeutics - Warrants(14/08/2029) sits higher the its sector benchmark (-5.68%) with a ROE of 11668.18%. That is roughly 205411.3% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A ROE of 11668.18% for Silexion Therapeutics - Warrants(14/08/2029) means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Silexion Therapeutics - Warrants(14/08/2029)'s ROE evolved across reporting periods, while the comparison chart places SLXNW next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.